tiprankstipranks
Trending News
More News >
ERYTECH PHARMA (FR:PHXM)
:PHXM
France Market

ERYTECH PHARMA (PHXM) Income Statement

Compare
2 Followers

ERYTECH PHARMA Income Statement

Last quarter (Q2 2024), ERYTECH PHARMA's total revenue was €546.50K, an increase of 293.17% from the same quarter last year. In Q2, ERYTECH PHARMA's net income was €-5.32M. See ERYTECH PHARMA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 1.33M€ 6.65M€ 4.18M€ 3.72M€ 5.28M
Gross Profit
€ 1.33M€ 3.74M€ -1.20M€ -1.27M€ 1.07M
Operating Expenses
€ 24.99M€ 29.18M€ 55.32M€ 67.56M€ 65.14M
Depreciation and Amortization
€ 1.61M€ 2.91M€ 5.38M€ 4.99M€ 4.22M
EBITDA
€ -22.93M€ 3.08M€ -49.38M€ -69.41M€ -60.83M
Operating Income
€ -23.66M€ -32.08M€ -60.70M€ -72.55M€ -69.36M
Other Income/Expenses
€ -1.07M€ 32.38M€ 2.72M€ -747.00K€ 6.70M
Pretax Income
€ -24.73M€ -1.19M€ -57.46M€ -76.73M€ -66.58M
Net Income
€ -23.49M€ -228.00K€ -53.80M€ -73.30M€ -62.66M
Per Share Metrics
Basic EPS
€ -5.00€ -0.07€ -20.99€ -36.85€ -32.29
Diluted EPS
€ -5.00€ -0.07€ -20.99€ -36.85€ -32.29
Weighted Average Shares Outstanding
4.70M 3.36M 2.56M 1.99M 1.94M
Weighted Average Shares Outstanding (Diluted)
4.70M 3.36M 2.56M 1.99M 1.94M
Currency in EUR

ERYTECH PHARMA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis